Introduction Male breast cancer (MBC) is a rare and inadequately characterized disease.
The aim of the present study was to characterize MBC tumors transcriptionally, to classify …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

Male breast cancer is a rare disease for which treatment has been based on the evidence
available from female breast cancer. The new genomic tools can better characterize the …

Introduction Male breast cancer (MBC) is a rare, yet potentially aggressive disease.
Although literature regarding female breast cancer (FBC) is extensive, little is known about …

Background Male breast cancer (MBC) is a rare disease accounting for approximately 1% of
all breast carcinomas. Presently treatment recommendations are derived from the standards …

Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …

Abstract In total,~ 25% of familial breast cancer (BC) is attributed to germline mutations of the
BRCA1 and BRCA2 genes, while the rest of the cases are included in the BRCAX group. BC …

Breast cancer in men is a rare disease, accounting for∼ 1% of all breast cancer cases.
Although the epidemiologic literature regarding female breast cancer is extensive, relatively …

Male breast cancer (MBC) is a rare disease. To date, therapy is mainly based on studies and
clinical experiences with breast cancer in women. Only little is known about molecular typing …

Purpose In order to better define the breast cancer (BC) genetic risk factors in men, a
germline investigation was carried out on 81 Male BC cases by screening the 24 genes …